| 000 | 01731 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517031953.0 | ||
| 264 | 0 | _c20160301 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2015.3746 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Huaizheng | |
| 245 | 0 | 0 |
_aEffect of BML-111 on the intestinal mucosal barrier in sepsis and its mechanism of action. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cAug 2015 |
||
| 300 |
_a3101-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCaspase 3 _xgenetics |
| 650 | 0 | 4 |
_aDefensins _xagonists |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Mucosal _xdrug effects |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xgenetics |
| 650 | 0 | 4 |
_aToll-Like Receptor 4 _xgenetics |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xgenetics |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aLiu, Zuoliang | |
| 700 | 1 | _aZhao, Shangping | |
| 700 | 1 | _aSun, Chuanzheng | |
| 700 | 1 | _aYang, Mingshi | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 12 _gno. 2 _gp. 3101-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2015.3746 _zAvailable from publisher's website |
| 999 |
_c24882384 _d24882384 |
||